David Sheridan Selected Research

David Sheridan Research Topics

5	Fibrosis (Cirrhosis) 10/2020 - 01/2016
4	Neoplasms (Cancer) 01/2021 - 01/2003
4	Chronic Hepatitis C 01/2019 - 10/2009
3	Infections 11/2020 - 09/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 03/2015
3	Leukemia 04/2006 - 01/2003
2	Ascites 10/2020 - 01/2020
2	Pruritus (Itching) 12/2019 - 10/2017
2	Non-alcoholic Fatty Liver Disease 12/2019 - 01/2016
2	Liver Diseases (Liver Disease) 01/2016 - 03/2015
2	Pain (Aches) 10/2015 - 10/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2006 - 01/2006
1	HIV Infections (HIV Infection) 01/2021
1	COVID-19 11/2020
1	Human Influenza (Influenza) 11/2020
1	End Stage Liver Disease 01/2020
1	Alcoholic Fatty Liver 12/2019
1	Obstructive Jaundice (Cholestatic Jaundice) 03/2019
1	Inflammation (Inflammations) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2017
1	Myalgia 10/2017
1	Dyspepsia (Indigestion) 10/2017
1	Dizziness (Lightheadedness) 10/2017
1	Nausea 10/2017
1	Spasm (Spasms) 10/2017
1	Hepatitis 01/2016
1	Chronic Hepatitis B 01/2016
1	Headache (Headaches) 10/2015
1	Umbilical Hernia (Omphalocele) 10/2014
1	Abdominal Pain (Pain, Abdominal) 10/2014
1	Breast Neoplasms (Breast Cancer) 10/2012
1	Virus Diseases (Viral Diseases) 09/2011
1	RNA Virus Infections 10/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2004
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2004
1	Hematologic Neoplasms (Hematological Malignancy) 12/2004
1	Lymphoma (Lymphomas) 01/2003

3	InterferonsIBA 03/2015 - 10/2009
3	Ribavirin (Virazole)FDA LinkGeneric 08/2014 - 10/2009
2	Interferon-alpha (Interferon Alfa)IBA 09/2011 - 10/2009
1	COVID-19 VaccinesIBA 11/2020
1	VaccinesIBA 11/2020
1	SolutionsIBA 01/2020
1	obeticholic acidIBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Biological ProductsIBA 01/2019
1	micaIBA 01/2019
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 10/2017
1	seladelparIBA 10/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017
1	Genetic Markers (Genetic Marker)IBA 02/2016
1	LipidsIBA 01/2016
1	microsomal triglyceride transfer proteinIBA 01/2016
1	A 17 (A-17)IBA 10/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2015
1	Interferon LambdaIBA 08/2014
1	HLA-C Antigens (HLA-C)IBA 09/2011
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2006
1	Etoposide (VP 16)FDA LinkGeneric 04/2006
1	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2006
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 04/2006
1	Decitabine FDA Link 01/2006
1	Histone Deacetylase 1IBA 01/2006
1	Messenger RNA (mRNA)IBA 12/2004
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2004
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 01/2003
1	antineoplaston A10 (A 10)IBA 01/2003

5	Therapeutics 10/2017 - 10/2009
3	Drug Therapy (Chemotherapy) 03/2019 - 04/2006
2	Palliative Care (Palliative Therapy) 10/2020 - 01/2020
1	Stem Cell Transplantation 01/2021
1	Immunomodulation 06/2017
1	Length of Stay 10/2015
1	Arthroplasty 10/2014
1	Aftercare (After-Treatment) 10/2012